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There are many well-studied examples of human phenotypes resulting from nonsense or frameshift mutations that are modulated
by Nonsense-Mediated mRNA Decay (NMD), a process that typically degrades transcripts containing premature termination
codons (PTCs) in order to prevent translation of unnecessary or aberrant transcripts. Diﬀerent types of germline mutations in
the VHL gene cause the von Hippel-Lindau disease, a dominantly inherited familial cancer syndrome with a marked phenotypic
variability and age-dependent penetrance. By generating the Drosophila UAS:Upf1D45B line we showed the possible involvement
of NMD mechanism in the modulation of the c.172delG frameshift mutation located in the exon 1 of Vhl gene. Further, by
Quantitative Real-time PCR (QPCR) we demonstrated that the corresponding c.163delG human mutation is targeted by NMD in
humanHEK293cells.TheUAS:Upf1D45B linerepresentsausefulsystemtoidentifynovelsubstratesofNMDpathwayinDrosophila
melanogaster. Finally, we suggest the possible role of NMD on the regulation of VHL mutations.
Copyright © 2009 Lucia Micale et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Background
Germline mutations in the VHL gene cause the von Hippel-
Lindau disease (VHL; MIM# 193300), a dominantly inher-
ited familial cancer syndrome with retinal and central
nervous system hemangioblastomas, renal cell carcinoma,
pheochromocytoma, pancreatic endocrine tumors, and en-
dolymphatic sac tumors [1–4]. The VHL mutation pattern
includes missense, nonsense, frameshift, and splice site
mutations. Genotype-phenotype correlation studies showed
that the incidence of renal involvement in VHL disease was
increased in families with nonsense or frameshift mutations
that disrupted the structural integrity of VHL protein,
whereas missense mutations associated with a higher risk of
pheochromocytoma [5–7].
We hypothesize that the genic localization of VHL
variations and nonsense mutations of VHL activating NMD
pathway may play an important role in the determination of
as p e c i ﬁ cp h e n o t y p e .
NMD is an evolutionarily conserved mRNA surveillance
pathway that protects cells from potentially harmful eﬀects
of truncated proteins that would otherwise be translated
from mRNAs bearing PTC. The process serves as a gen-
eral surveillance mechanism to abolish aberrant transcripts
resulting not only from rare mutations but also from
mistakes in RNA processing [8], regulating the expression
of about 3%–10% of the transcriptome in S. cerevisiae, D.
melenogaster, and human cells. These natural NMD targets
play a role in diﬀerent biological processes such as tran-
scription, cell proliferation, cell cycle, telomere maintenance,
cellulartransportandorganization,andmetabolism[9].The
high evolutionary conserved Upf proteins, Upf1, Upf2, and
Upf3, constitute the core of NMD machinery [10–14]. The
key molecular component is Upf1, an RNA helicase that
recognizes aberrant translation termination events [15].
Althoughconservedinalleukaryotesthathavebeenanal-
ysed so far, NMD employs diﬀerent molecular mechanisms,
depending on the species, to discriminate between natural2 Journal of Biomedicine and Biotechnology
and premature stop codons and to degrade the targeted
mRNAs. In mammalian cells, termination codons that lie
upstreamofanexon-exonboundaryaregenerallyrecognized
asprematureandtargetthemRNAfordegradationbyNMD.
The Drosophila melanogaster intron-less Vhl gene maps
at polytene chromosomal position 47E5-6 (http://ﬂybase
.org/). The human and ﬂy proteins show a high degree of
amino acid similarity spread throughout the entire length
of VHL with 67% and 76% of similarity in the functional
domains of PKCl and elongin C binding domains, respec-
tively.
Here, by establishing a Drosophila NMD mutant, we
showed the involvement of NMD mechanism in the mod-
ulation of a novel human VHL frameshift mutation and we
conﬁrmed this data in the HEK 293 human cell line using a
molecular strategy based on the minigene constructs.
2. Methods
2.1. Fly Strains and Culture Conditions. Flies were cultured
at 25
◦C on standard cornmeal-sucrose-yeast-agar medium
containing propionic acid as mold inhibitors. Detailed
description of mutations and chromosome rearrangements
used in the present study could be found at FlyBase:
http://ﬂybase.bio.indiana.edu. The stocks used in the present
work were supplied by Bloomington Stock Center.
2.2. Northern Blotting Assays. T o t a lR N A sf r o mt e s t e sa n d
ovaries of adult ﬂies were isolated using RNeasy Kit (Qia-
gen) and poly(A)
+ RNAs were prepared with oligo(dT)-
coupled beads (Oligotex, Qiagen). RNAs were separated
in denaturing formaldehyde agarose gel (5–20μg/lane) and
blotted onto positively charged nylon membranes (Amer-
sham). Upf1 and Rp49 32P-labeled probes were generated
by random priming using standard methods. Hybridization
was carried out overnight at 65
◦C in hybridization solution
(formamide 50%, SSC 5x, Denhardt’s 5x, SDS 0.5x, EDTA
pH 8.0 10mM, Salmon Sperm DNA 100g/mL). After
hybridization, the membranes were washed four times at
65
◦C. Autoradiography was carried out for both 16 and
48 hours at −80
◦C using intensifying screens. Filters were
stripped and hybridization was repeated with a Rp49 specic
probe.
2.3. Genetics Mutants. The Adh alleles were previously
characterized by Brogna [16]. The Adhn4 allele contains a
premature stop codon located 258bp upstream from the
boundary between exon 3 and exon 4 while Adhfn 6 is a small
deletion that eliminates the 5  splicing signal of intron 2
leading to an in-frame premature stop codon (Figure 1(a)).
2.4. Isolation of Full Length Upf1 cDNA. Drosophila genomic
DNA was isolated from adults using Genomic DNA Extrac-
tion Kit (Qiagen). As probe for subsequent screens, a
fragment of 700bp was PCR ampliﬁed from genomic
D N Aa st e m p l a t e( Upf1F and Upf1R primers in Table 1).
The identity of cloned PCR product was conﬁrmed by
sequencing. For the isolation of the Upf1 cDNA full-length, a
Drosophila melanogaster ovaric cDNA library was screened
using that Upf1-probe. Hybridization of the Hybond-N+
ﬁlters (Amersham) was carried out at 65
◦C according to the
manufacturer’s instructions. The positive Upf1 cDNA clone
was cloned into the pGEM-T-Easy vector (Promega) and
veriﬁed by DNA sequencing.
2.5. UAS:Upf1D45B Negative Dominant and UAS:Vhln1 and
UAS:Vhln2 Nonsense Mutant Lines. The entire coding
sequence of the Vhl gene was ampliﬁed by PCR with Pfu
Polymerase (Promega) using cDNA obtained by reverse
transcription of total RNA extracted from adult ﬂies. The
PCR fragment was inserted into the pcDNA3 vector and
veriﬁed by direct sequencing. The Upf1 and Vhl mutations
were introduced in the cloned cDNAs by site-directed
mutagenesis with the QuickChange II kit (Stratagene) using
the following oligonucleotides: Upf1Fmut and Upf1Rmut for
Upf1, Vhln1Fa n dVhln1Rf o rVhln1,a n dVhln2Fa n dVhln2R
for Vhln2 mutations (Table 1), respectively. Subsequently,
mutated Upf1 and Vhl cDNAs were sequenced and inserted
into pUAST vector by site directed cloning.
P element transformation was performed by microin-
jection of pUAST:Upf1 or pUAST:Vhl together with a Δ2-
3 transposase containing plasmid into a w1118 Drosophila
melanogaster strain [17]. Multiple lines were obtained for
eachinjectedconstruct.Theexpressionofdiﬀerentupstream
activating sequences (UASs) constructs was tested using a
pGAL4 line that drives ubiquitous expression.
The Upf1 dominant negative activity of the trans-
genic lines selected was tested by crossing virgin females
w1118;β2::GAL4 with w1118; Adhn4/Cy; UAS:Upf1D45B/TM3
and w1118; Adhfn 6/Cy; UAS:Upf1D45B/TM3,r e s p e c t i v e l y .T h e
β2::GAL4 line drives the transgene expression in the
testis. The levels of Adh and Upf1 mRNA from testes
of w1118; Adhn4/β 2::GAL4; UAS:Upf1D45B/+ and w1118;
Adhfn 6/β2::GAL4; UAS:Upf1D45B/+ ﬂies and the levels of Vhl
from testes of w1118;U A S :Vhln1/β2::GAL4; UAS:Upf1D45B/+
and w1118;U A S :Vhln2/β2::GAL4; UAS:Upf1D45B/+ ﬂies were
analysed by QPCR.
2.6. Reverse Transcription PCR (RT-PCR) and Quantitative
Real-Time PCR (QPCR). Total RNA from testis of 50 adult
ﬂies was obtained using RNeasy Mini Kit and reverse tran-
scripted using QuantiTect Reverse Transcription Kit (Qia-
gen) according to the manufacturer’s instructions. RT-PCR
wasperformedusingpVHLFandpVHLRandAdh RT Fand
Adh RT Rp r i m e r sf o rVhl and Adh,r e s p e c t i v e l y( Table 1).
QPCR was carried out in triplicates using Platinum SYBR
Green qPCR SuperMix-UDG (Invitrogen) and run on ABI
7900HT Sequence Detection System with defaults parame-
ters. The geometric mean of two reference genes (Rp49 and
Act4A) was used to normalize the relative quantities. The
calculations were made using the Comparative CT method
as reported (User Bulletin #2, Applied Biosystems).
2.7. Minigenes Construct. Construct 1 (Figure 3(a)). We
ligated two PCR fragments from DNA of healthy individ-
ual carrying wild type VHL alleles. The PCR fragmentsJournal of Biomedicine and Biotechnology 3
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Figure 1: Schematic map of the Adh gene. (a) Rectangles represent exons; black box represents promoter region; hatched boxes indicate
coding regions; punctated boxes represent untranslated regions. The horizontal lines represent introns, IN1-IN3. The position of the
mutations are indicated with vertical lines marked with a star; Adhfn6 is the mutation aﬀecting splicing while Adhn4 is a nonsense mutation.
(b) and (c) Compared levels of Adh and Upf1 transcripts in ﬂies that were heterozygous for Adh alleles and for Upf1D45B. A 3.8- and 8.8-fold
accumulation of nonsense-containing Adh mRNA was observed in w1118; Adhn4/β2::GAL4; UAS:Upf1D45B/+ and w1118;Adhfn6/β2::GAL4;
UAS:Upf1D45B/+ mutant ﬂies with respect to the endogenous levels of Adh and Upf1 control mRNAs. The experiment was repeated three
times.
contained exon 1 and part of its downstream intronic
sequence (700bp) and exon 2 and part of its ﬂanking introns
(390bp at intron 1 and 134bp at intron 2). The PCR
fragments were ampliﬁed using the primers listed in Table 1.
The diﬀerent constructs were cloned into the pcDNA3.1
vector (Invitrogen). The c.163delG mutation was introduced
by site-directed mutagenesis using the QuickChange II kit
(Stratagene) with the generation of a stop codon in exon1
(V66X).
Construct 2 (Figure 3(b)). The entire coding sequence of
the VHL gene was ampliﬁed by PCR using as template the
cDNA obtained by reverse transcription of RNA extracted
from HEK293 cells. The c.239delG stop codon mutation was
introduced by site-directed mutagenesis.
2.8. Transfection, RNA Extraction, and QPCR on HEK 293
Cell Lines. HEK 293 cells were grown at 37
◦Ci nD M E M
supplemented with 10% fetal calf serum and 1% penicillin-
streptomycin (Invitrogen). They were seeded at 1 × 106 cells
per100mmdiameterpetridish24hoursbeforetransfection,
performedbyFugeneHD(Roche)witheither1μgofVHLwt
or mutant constructs. A GFP plasmid was used as a reference
for transfection eﬃciency in each cell line. The mRNA levels
of the diﬀerent constructs were normalized to the mRNA
level of GFP. Then, the ratio between the normalized mRNA
levels transcribed from the mutant and the wt constructs
following CHX treatment was calculated and compared with
this ratio in untreated cells. The experiments were repeated
at least three times.
3. Results
3.1. RT-PCR Analysis Reveals that Upf1, Adh, and Vhl Are
Expressed in Ovaries and Testes of Adult Flies. To test whether
Drosophila testis expresses detectable levels of the endoge-
nous Upf1, Adh,a n dVhl genes, we performed Northern blot
and RT-PCR analysis on poly(A)
+ and total RNA extract
from ovaries and testes of adult ﬂies. As shown in Figure 4
these analyses revealed that Upf1, Adh, and Vhl are normally
expressed in ovaries and testes of adult ﬂies.
3.2. Upf1 Dominant-Negative Mutant Abolish Degradation of
Nonsense Transcripts in Drosophila melanogaster. The yeast
R779C and mammals R844C Upf1 mutations convert the
conserved arginine to cysteine at residue 799 and 844
respectively, within the RNA helicase domain, conferring a4 Journal of Biomedicine and Biotechnology
Table 1: Primer’s list used in this study.
Name Sequence 5 -3  Utilization
Upf1F TTGGAATCATCACGCCTTACGA Upf1 probe
Upf1R CATGCCAACCGGAACTGGCATG Upf1 probe
Upf1Fmut ATGTCTTGCGTGTGTTCTAACGAACGT Mutagenesis
Upf1Rmut ACGTTCGTTAGAACACACGCAAGACAT Mutagenesis
Vhl
n1F CCCTCAAGCCCTTCAGGAGGTGCGGGTGAAC Vhl
n1 mutagenesis
Vhl
n1R GGGAGTTCGGGAAGTCCTCCACGCCCACTTG Vhl
n1 mutagenesis
Vhl
n2F GGATGCACGTACGCTGCAGAGGATCTTTCA Vhl
n2 mutagenesis
Vhl
n2R TGAAAGATCCTCTGCAGCGTACGTGCATCC Vhl
n2 mutagenesis
Vhl
n1F construct1(EcoRI) CGCGCGGAATTCATGCCCCGGAGGGCGGAGAACT Construct1
Vhl
n1R construct1(XhoI) CGCGCGCTCGAGATGGTGAAACCCCGTCTCTACT Construct1
Vhl
n1F1 construct1(XhoI) CGCGCGCTCGAGTCAGGGGAAATGGAGAAAATAG Construct1
Vhl
n1R1 construct1(XbaI) CGCGCGTCTAGAGAGAATAGGATACAAAAAGATTGGA Construct1
c.163delGF ACTGGGCGCCGAGGAGGAGATGAGGCCGGGCGGCCGC Construct1 mutagenesis
c.163delGR GCGGCCGCCCGGCCTCATCTCCTCCTCGGCGCCCAGT Construct1 mutagenesis
Vhl
n2F construct2(EcoRI) CGCGCGGAATTCATGCCCCGGAGGGCGGAGAACT Construct2
Vhl
n2R construct2(XhoI) CGCGCGCCTCGAGTCAATCTCCCATCCGTTGATGTGC Construct2
c.172delGF CAGGTCATCTTCTGCAATCGCATCCGCGCGTCGTGCT Construct2 mutagenesis
c.172delGR AGCACGACGCGCGGATGCGATTGCAGAAGATGACCTG Construct2 mutagenesis
pVHLF GGCCGCCGCATCCA VHL QPCR
pVHL R CATCGTGTGTCCCTGCATCTC VHL QPCR
pGFP F GCAACTACAAGACCCGC GFP QPCR
pGFP R GTCGGCCATGATATAGACG GFP QPCR
rp49 F CACACCGGAAACTCAATGGAT rp49 QPCR
rp49 R GGTCATCTTGAAGCTGGAAGG rp49 QPCR
Act4A F GCTTCGCTGTCTACTTTCCA Act4A QPCR
Act4A R CAGCCCGACTACTGCTTAGA Act4A QPCR
Adh RT F GGCGGTCCCGGTGGTA RT-PCR, Adh QPCR
Adh RT R CTGGTAGATGGCATTGAATCC RT-PCR, Adh QPCR
dominant-negative eﬀe c to ny e a s ta n dh u m a nU p f 1 pa c t i vi ty
in nonsense-mediated mRNA decay pathway [18]. Because
of the high identity of Drosophila UPF1 protein with the
human and yeast Upf1 protein (67% and 53%, resp.) we
introduced the same mutation into the ﬂy Upf1 cDNA and
we tested whether this mutation in vivo exerts a dominant
negative eﬀect on the regulation of alcohol dehydrogenase
gene, Adh, a speciﬁc substrate of NMD, by utilizing the
heterologous GAL4-UAS binary expression system [19].
By screening of a Drosophila melanogaster adult ovaric
cDNA library with a Upf1 probe we isolated one positive
clone that consisted of an Upf1 full-length containing an
open reading frame of 3530 bp with a 5 -untranslated region
of372bpanda3 -untranslatedregionof802bp,respectively.
Using directed mutagenesis we generated Upf1 cDNA
that carries the R822C substitution that mimics the yeast
R779C and mammals R844C Upf1 mutations. This mutated
Upf1 cDNA was cloned into P element expression vec-
tors under the control of yeast GAL4-UAS. P element-
mediated germ line transformation was used to generate an
UAS:Upf1 transgenic ﬂy line that we called UAS:Upf1D45B.
Weobservedthattheubiquitousexpressionofthedominant-
negative UPF1D45B protein, driven by actin-GAL4 driver line
(P{Act5C − GAL4}17bFO1), caused 100% larval lethality
(0/1445). Consistently, the observed phenotype and the
eﬃcacy of UAS:Upf1D45B transgene were conﬁrmed by
isolation and characterization of a loss-of-function mutation
intheDrosophilaUpf1genethatcauseslethalityduringlarval
development [14].
To verify whether Upf1D45B is able to modulate NMD
pathway, we used QPCR to test its eﬀect on mRNA levels
of Adhn4 and Adhfn 6, two nonsense mutations of the
alcohol dehydrogenase gene (Adh)( Figure 1(a)), known to
b et a r g e t e db yN M Di nS 2c e l l sa n di nv i v o[ 14, 20]. First,
we measured the levels of Adh mRNA in both Adh mutant
strains and we detected, in agreement with previous dataJournal of Biomedicine and Biotechnology 5
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Figure 2: QPCR to measure the levels of transgenic Vhl lines. (a) Schematic map of the Vhl gene. Black rectangles represent the promoter
region; hatched box represents the coding region; punctated boxes represent untranslated regions. The position of the point mutations n1
and n2 are indicated with vertical lines marked with a star. (b) and (c) We compared the levels of Vhl and Upf1 transcripts in ﬂies that were
heterozygous for Vhl nonsense alleles and for Upf1D45B. No increase of Vhl transcript in transgenic UAS:Vhln2 line was observed under the
inhibition of NMD pathway whereas the UAS:Vhln1 transgenic line showed a 1.8 accumulation of nonsense-containing Vhl mRNA. The
experiment was repeated three times.
[20], that they were 25% and 10% lower compared to the
wild type strain (data not shown), because of increased
turnover of the mutant transcript by the NMD pathway.
Since the ubiquitous expression of UPF1D45B protein
caused larval lethality, we reasoned that the choice of a tissue
in which the absence of the NMD pathway is not essential for
Drosophila viability or development is fundamental to carry
out functional analysis on NMD targets.
Interestingly, we observed that the expression of
UPF1D45B protein in Drosophila testis, driven by a testis-
speciﬁc GAL4 driver line (β2::GAL4), had no eﬀect on testis
development and/or larval lethality. Thus, we retained that
theuseofβ2::GAL4driverlinecouldallowadetailedanalysis
of adult-onset phenotypes induced by loss of UPF1 activity.
Further,wetested whethertheUpf1 mutationhasadom-
inant-negative eﬀect on the regulation of Adhn4 and Adhfn 6
transcripts by inducing the expression of UAS:Upf1D45B
transgene in Drososphila testis. w1118; Adhn4/Cy; UAS:
Upf1D45B/TM3 and w1118; Adhfn 6/Cy; UAS:Upf1D45B/TM3
males were crossed to β2::GAL4 females and the levels
of Adh and Upf1 mRNAs from testes of w1118;A d h n4/
β2::GAL4; UAS:Upf1D45B/+ and w1118; Adhfn 6/β2::GAL4;
UAS:Upf1D45B/+ ﬂies were measured by using QPCR. Con-
sistently with [11] we observed a 3.8- and 8.8-fold accumu-
lation of Adh mRNA when compared to the control (Figures
1(b) and 1(c)), implying that the expression of UPF1D45B
mutation could abolish NMD pathway function.
Together these results strong point out that Upf1D45Bline
represents a useful system to conduct a functional study to
identify possible substrates of NMD pathway in Drosophila
melanogaster.
3.3. Vhl Gene Is a Target of NMD in Drosophila melanogaster.
The UAS:Upf1D45Bline was used to investigate whether Vhl
alleles carrying PTCs are degraded by NMD pathway. We
constructed two diﬀerent Vhl nonsense mutants by using
site-directed mutagenesis strategy. The Vhln1allele contains
the c.172delG frameshift mutation located in the exon 1
of Vhl gene. This mutation corresponds to the human
c.163delG pathogenic mutation that we recently identiﬁed
in a sporadic case of human cerebellar hemangioblastomas
(Muscarella, submitted). The Vhln2 allele contains the
c.254delC mutation corresponding to the c.239delG in
human VHL gene (Figure 2(a))[ 21].
P element-mediated germ line transformation was used
to generate two independent transgenic ﬂy lines carrying Vhl
mutations, UAS:Vhln1 and UAS:Vhln2.
To verify whether the two diﬀerent Vhl mutant trans-
cripts were targeted by NMD pathway, w1118;U A S :Vhln1/
Cy; UAS:Upf1D45B/TM3 and w1118;U A S :Vhln2/Cy; UAS:
Upf1D45B/TM3 males were crossed to w1118;β2::GAL4 fema-
les. The mRNA levels of both wild type and mutated forms
of Vhl and Upf1 from testis of w1118;U A S :Vhln1/β2::GAL4;6 Journal of Biomedicine and Biotechnology
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Figure 3: Eﬀect of CHX treatment on the level of the c.163delG and c.239delG VHL mRNA. (a) Scheme of the WT (upper panel) and
c.163delG constructs, which contained the exons 1-2 (marked in the boxes by numbers), a part of the intronic sequence between exons
1-2 and a piece of intron downstream the exon 2. The CMV promoter is marked by a thick horizontal arrow. (b) Scheme of the WT and
c.239delG construct containing the entire coding sequence of the VHL gene. (c) and (d) QPCR analysis of VHL transcripts before and
following CHX treatment. The level of mRNA transcribed from VHL construct carrying either the wild type sequence or the c.163delG and
c.239delG mutations was normalized to the mRNA level of GFP. The ratio between these normalized levels following CHX treatment was
calculated and compared with the ratio in untreated cells. The fold increase in the level of VHL c.163delG and c.239delG transcripts is shown
as mean ± SEM.
UAS:Upf1D45B/+ and w1118;U A S :Vhln2/β2::GAL4; UAS:
Upf1D45B/+ ﬂies were measured by QPCR. We observed an
increased of Vhl transcript in UAS:Vhln1/β2::GAL4; UAS:
Upf1D45B/+ transgenic line. Conversely, the UAS:Vhln2/
β2::GAL4;UAS:Upf1D45B/+ ﬂies did not show any diﬀerence
in Vhl expression compared to the Upf1 wild type line
(Figures 2(b) and 2(c)).
3.4. VHL Mutations Are Targeted by NMD in Human Cell
Lines. To investigate the stability of VHL wild type and
certain human nonsense transcripts, we measured by QPCR
the mRNA levels of constructs carrying wild type, c.163delG
and c.239delG (Figures 3(a) and 3(b)) VHL mutations
transfected into HEK 293 cells in absence and presence of
cycloheximide (CHX), a widely used inhibitor of NMD. The
analysisshowedthatthe foldincrease diﬀers betweenthe two
mutants, with a modest increase in the level observed (1.4 ±
0.10) for c.239delG and a higher increase of 2.0 (2.4 ± 0.8)
for c.163delG (Figures 3(c) and 3(d)).
4. Discussion
In humans, the role of NMD as a modiﬁer of the phenotypic
consequences of PTC is becoming more apparent. There
are a consistent number of genetic diseases in which NMD
partially mitigates the consequences of mutation owing to
phenotypic variability.
The VHL is a well-known tumor suppressor gene,
involved in cell cycle, regulation of hypoxia inducible genes
and proper ﬁbronectin assembly in extracellular matrix
[22]. Germline mutations of the VHL gene lead to the
development of the von Hippel-Lindau disease, a rare dom-
inantly inherited familial cancer syndrome with a marked
phenotypic variability and age-dependent penetrance.
The number of mutations in VHL gene is enormous
and includes missense, nonsense, frameshift, and splice site
mutations. In the past few years many diﬀerent approaches
using several molecular gene parameters have been used to
make a possible correlation between VHLgene mutation and
tumor phenotype [5–7, 23].Journal of Biomedicine and Biotechnology 7
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Figure 4: Upf1, Adh, and Vhl expression in Drosophila testes and
ovaries. (a) Northern blot analysis of poly (A+) RNAs isolated
from wild type adult ﬂies. Lane 1: poly(A+) RNA from ovaries of
adult females; lane 2: poly(A+) RNA from testes of adult males.
Arrowheads on the left mark the position of the detected mRNAs.
(b) RT-PCR analysis of Adh transcripts in wild type adult ﬂies. Lane
1: total RNA from ovaries of adult females; lane 2:t o t a lR N Af r o m
testesofadultmales;lane3:negativecontrol.(c)RT-PCRanalysisof
Vhl transcriptsinwildtypeadultﬂies.Lane1:totalRNAfromtestes
of adult males; lane 2: total RNA from ovaries of adult females; lane
3: negative control.
In the present study we generated Upf1 mutant ﬂy line,
UAS:Upf1D45B, to investigate whether two nonsense alleles
of the Vhl gene are NMD targets. In agreement with others
we observed that the ubiquitous expression of UPF1D45B
protein, induced by a speciﬁc actin-GAL4 driver line, causes
100% larval lethality [14].
NMD pathway modulates the activity of speciﬁc native
transcripts, whose misregulation would perturb the devel-
opment or function of select cells or tissues and leading to
lethality. Since Upf1 gene is broadly expressed and active
throughout development, identiﬁcation of the tissue target
of Upf1 lethality will be an important ﬁrst step to select the
cellular substrates of NMD gene regulation.
Since the expression of UAS-transgene can be targeted
to a speciﬁc tissue using the GAL4/UAS binary expression
system, for our experiments we have chosen the β2::GAL4
line that drives the transgene expression in a region of testis
in which the perturbation of NMD pathway is not essential
for Drosophila viability and development.
The observed abolishing eﬀect of degradation of Adh
nonsense transcript, an NMD substrate, by Upf1 domi-
nant-negative mutant suggested that the UAS:Upf1D45B line
couldbeusedasgeneticsystemtoscreennonsensemutations
substrate of NMD pathway.
We investigated if the expression of two speciﬁc Vhl
nonsense transcripts, Vhln1 and Vhln2,i sm o d u l a t e db y
NMD mechanism. The observed eﬀect of NMD on the
degradation of these two Vhl nonsense transcripts was
diﬀerent. In particular we showed the involvement of NMD
in the degradation of Vhln1 transcript, whereas Vhln2
transgenic line showed no diﬀerence in Vhl expression
compared to the wild type. These results suggest that the
NMD of Vhl transcript carrying the c.172delG mutation is
eﬀective, whereas the c.254delC is not.
Similar results were observed in HEK293 cell line trans-
fected with VHL constructs harboring the corresponding
human VHL mutations after CHX treatment. Indeed while
the c.239delG mutation transcript level showed only a
marginal increase following the NMD inhibition, a fairly
good increase of mRNA expression of c.163delG mutant
transcript was observed.
Ourdataconﬁrmthatsomeframeshiftmutationslocated
in the last portion of VHL g e n ec o u l de s c a p eN M D .I nf a c ti n
both mammalian cells and Drosophila the c.239delG and the
c.254delC transcripts, respectively, are immune to NMD.
Not all nonsense codons trigger NMD. In mammalian
cells a splicing-dependent signal seems to be involved in PTC
deﬁnition. Remarkably, stop codons located at least 50–55nt
upstream of an exon-exon boundary are generally deﬁned
as premature, whereas most PTCs downstream of this point
do not elicit decay [24]. Notably, although the splicing and
NMD machineries are conserved in D. melanogaster, the
NMD in this organism was shown to occur independently of
EJC components and PTC-containing transcripts that derive
from intronless genes were found to be NMD-competent
[11, 25].
Recent data demonstrated that the position of nonsense
codons relative to the cytoplasmic poly(A)-binding protein 1
(PABPC1) is also a critical determinant for PTC deﬁnition
both in Drosophila a n di nh u m a n[ 26]. Interestingly, if
PABPC1isincloseproximitytothePTC,itseemstofunction
asanNMDrepressor.TheobservationthattheVhln1 butnot
the Vhln2 mRNA abundance is subject to NMD regulation
might be attributable to the spatial rearrangements of the
3 UTR that close PABPC1 to the PTC. Probably, proximity
of the PABPC1 protein to the PTC generated by c.172delG
mutation inhibits NMD.
Another possible explanation for the diﬀerence observed
between the two mutants should be that whereas the
c.163delG mutation is located suﬃciently upstream of an
exon-exon junction and therefore is able to trigger NMD, the
c.239delGmutationislocatedinthe3 -mostexon.Therefore
it is not surprising that this mutation is not able to trigger
NMD in mammalian cells.
The possibility that VHL truncating mutations may
recognised by NMD was recently veriﬁed [6]. In that study,
inhibition of NMD in two sporadic RCC cell lines (786O
and KTCL26) with endogenous frameshift VHL mutations
that generated stop codons at residues 104 and 147 amino
acidic composition residues, respectively, did not produce8 Journal of Biomedicine and Biotechnology
major changes in VHL mRNA expression (1.6- and 0.4-
fold increase following emetine treatment, unpublished
observations). The authors concluded that the NMD is not
eﬀective on the modulation of VHL because of the small
length of VHL gene that consists of only three exons [6].
5. Conclusions
Our experiments conﬁrm the utility of Drosophila melan-
ogaster as an easy experimental system for understanding
the NMD mechanism with a relevant potential applicability.
Further molecular investigations on a greater number of
Drosophila transgenic lines harbouring mutations that result
in truncated proteins in diﬀerent regions of Vhl gene or
whatever also gene will be need to get more indications
on the correlations between mutation position, activation
of NMD in Drosophila, and speciﬁcation of a deﬁnite
phenotype.
Finally, a larger number of mutations need to be tested
to deﬁnitely establish whether the NMD is involved in the
pathogenesis of von Hippel Lindau disease.
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